Site-specific glycosylation patterns on circulating TREM2 ectodomain fragments reflect the metabolic state and activation history of CNS microglia, serving as predictive biomarkers for anti-neuroinflammatory therapeutic responses. The hypothesis posits that microglial priming states differentially regulate glycosyltransferase expression (particularly ST6GAL1, MGAT5, and FUT8), leading to distinct N-linked and O-linked glycan signatures on TREM2 ectodomains shed into circulation. Unlike CSF fragm
## Mechanistic Overview
Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin starts from the claim that modulating CHI3L1/TREM2/NRGN within the disease context of biomarkers can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin starts from the claim that modulating CHI3L1/TREM2/NRGN within the disease context of biomarkers can redirect a disease-relevan
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
TREM2Neuroinflammationbiomarkers
Convergent signals
TREM2 recurs across 2 selected hypotheses with aligned directionality in neuroinflammation.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
1/11
dimensions won
Plasma TREM2 Ectodomain Glycosylation Pa
11/11
dimensions won
Integrated Multi-Analyte CSF Panel Combi
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.46
0.65
Evidence
0.27
0.68
Novelty
0.40
0.65
Feasibility
0.00
0.82
Impact
0.00
0.78
Druggability
0.50
0.70
Safety
0.25
0.85
Competition
0.28
0.72
Data
0.62
0.80
Reproducible
0.35
0.65
KG Connect
0.50
0.50
Score Breakdown
Dimension
Plasma TREM2 Ectodomain Glycos
Integrated Multi-Analyte CSF P
Mechanistic
0.455
0.650
Evidence
0.270
0.680
Novelty
0.400
0.650
Feasibility
0.000
0.820
Impact
0.000
0.780
Druggability
0.500
0.700
Safety
0.250
0.850
Competition
0.275
0.720
Data
0.618
0.800
Reproducible
0.350
0.650
KG Connect
0.500
0.500
Evidence
Plasma TREM2 Ectodomain Glycosylation Pattern as Therapeutic
Plasma TREM2 Ectodomain Glycosylation Pattern as T
4 rounds · quality: 0.75
Persona-Theorist
# Biomarker Hypotheses for Detecting Microglial Priming States
---
## Hypothesis 1: TSPO PET Kinetic Modeling for Priming State Discrimination
**Title:** Distinguishing primed from dystrophic micro...
Persona-Skeptic
# Critical Evaluation of Microglial Priming Biomarker Hypotheses
## Hypothesis 1: TSPO PET Kinetic Modeling
### Weak Links
**Specificity Crisis.** TSPO is expressed on microglia, astrocytes, endoth...
Persona-Domain Expert
# Feasibility Assessment: Microglial Priming Biomarkers
## Executive Summary
The debate identified a fundamental translational gap: even validated microglial targets remain therapeutically inaccessi...
# Biomarker Hypotheses for Detecting Microglial Priming States
---
## Hypothesis 1: TSPO PET Kinetic Modeling for Priming State Discrimination
**Title:** Distinguishing primed from dystrophic micro...
Persona-Skeptic
# Critical Evaluation of Microglial Priming Biomarker Hypotheses
## Hypothesis 1: TSPO PET Kinetic Modeling
### Weak Links
**Specificity Crisis.** TSPO is expressed on microglia, astrocytes, endoth...
Persona-Domain Expert
# Feasibility Assessment: Microglial Priming Biomarkers
## Executive Summary
The debate identified a fundamental translational gap: even validated microglial targets remain therapeutically inaccessi...